MolNFT v1 · #81857 · protein

Complex of shv S130G mutant beta-lactamase complexed to SA2-13

3V50: “Complex of shv S130G mutant beta-lactamase complexed to SA2-13”. X-ray diffraction, 2 ligands (MA4, SA2), 2 pockets (best druggability 0.67). MolNFT v1 #81857 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB: 3V50
Type: protein
Length: 265 residues
Chains: 1
Method: x-ray diffraction
Collection: MolNFT v1 / PDB
Contract: 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner: 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule: Beta-lactamase
EC: 3.5.2.6
UniProt: Q5PSW7
Ligands: MA4, SA2
Pockets: 2 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 17% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	Beta-lactamase (EC 3.5.2.6)	protein	265	45% helix, 17% strand	Q5PSW7

Ligands and binding sites

MA4 · Cyclohexyl-hexyl-beta-D-maltoside · ligand · 2 copies · chains A
SA2 · (3R)-4-[(4-carboxybutanoyl)oxy]-N-[(1E)-3-oxoprop-1-en-1-yl]-3-sulfino-D-valine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	221	0.67	0.84	25	MA4
2	87	0.33	0.74	17	SA2

Modifications

Observed in the structure: 1 covalent, 1 disulfide (covalent ligand, disulfide).

Compared structures

3V50 · Complex of SHV S130G mutant beta-lactamase complexed to SA2-13 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt Q5PSW7
Elsewhere: RCSB PDB 3V50 · PDBe 3V50 · UniProt Q5PSW7

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.